4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-004474
CEO bought 11,856 shares at $5.63 ($66,749)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2023-05-23 | Purchase | +11,856 | $5.63 | $66,749 | 1,065,375 | D |
| Open-market purchases · 11,856 sh · avg $5.63 · $66,749 | |||||||
Loading xslF345X04/primarydocument.xml…